➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Express Scripts
Baxter
Moodys
AstraZeneca

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Patent: 7,896,763

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,896,763
Title:Ball bat exhibiting optimized performance via selective placement of interlaminar shear control zones
Abstract: A ball bat exhibits improved barrel performance in regions located away from the \"sweet spot\" of the bat barrel, as a result of strategic placement of interface shear control zones (\"ISCZs\") in the barrel. The ball bat includes a barrel having a first region adjacent to the tapered section of the ball bat, a second region adjacent to the free end of the barrel, and a third region located between the first and second regions, that includes the sweet spot of the barrel. The first and second regions each include at least one interface shear control zone. The third region includes at least one fewer interface shear control zone than at least one of the first and second regions. ISCZs may also be strategically placed in the bat handle and/or the tapered section of the ball bat to improve the compliance and overall performance of the ball bat.
Inventor(s): Giannetti; William B. (Van Nuys, CA), Chauvin; Dewey (Simi Valley, CA), Chuang; Hsing-Yen (Studio City, CA)
Assignee: Easton Sports, Inc. (Van Nuys, CA)
Application Number:12/423,553
Patent Claims:see list of patent claims

Details for Patent 7,896,763

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial Easton Sports, Inc. (Van Nuys, CA) 2024-07-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
McKesson
Merck
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.